Imexpharm Corporation
Chất lượng hàng đầu. Tiêu chuẩn Châu Âu
Chất lượng hàng đầu. Tiêu chuẩn Châu Âu
Imexpharm Corporation is a leading pharmaceutical manufacturing company established in 1977 in Dong Thap Province, Vietnam. With its commitment to excellence in quality and innovation, Imexpharm has invested significantly in research and development, technology, infrastructure, production processes, and human resources to ensure compliance with advanced world standards, including EU-GMP. Currently owning three EU-GMP factories and 11 production lines, Imexpharm stands out as the pharmaceutical manufacturer with the largest cluster of EU-GMP factories in Vietnam. In 2020, Imexpharm received a significant Corporate Round investment from SK Investment, a member of the SK Group, which is the second-largest economic conglomerate in South Korea and listed in the Global Fortune 500. This investment is expected to provide Imexpharm with a strong financial foundation and international management experience, enabling the company to further expand its operations and become the largest pharmaceutical manufacturing company in Vietnam, catering to both domestic and export market demands.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Corporate Round | Unknown | 1 |
|
03 Jun 2020 |
No recent news or press coverage available for Imexpharm Corporation.
We care about your data, and we'd love to use cookies make your experience better.